This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Derma Sciences, Inc.
Derma Sciences, Inc., a prominent player in the wound care and advanced medical device industry, is headquartered in the United States. Founded in 1984, the company has established itself as a leader in innovative solutions for wound management, particularly through its advanced dressings and regenerative medicine products. With a focus on enhancing patient outcomes, Derma Sciences offers a range of unique products, including their proprietary MEDIHONEY® line, which harnesses the natural healing properties of honey. The company has achieved significant milestones, including strategic partnerships and a robust presence in both domestic and international markets. Recognised for its commitment to quality and innovation, Derma Sciences continues to set industry standards, making it a trusted name among healthcare professionals and patients alike.
DitchCarbon Score
How does Derma Sciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Derma Sciences, Inc.'s score of 44 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Derma Sciences, Inc., headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Integra LifeSciences Holdings Corporation, which may influence its climate commitments and reporting practices. As of now, Derma Sciences has not established any documented reduction targets or initiatives related to the Science Based Targets initiative (SBTi). Furthermore, there are no climate pledges or specific reduction initiatives outlined in their current framework. Given the lack of direct emissions data, it is essential to consider the broader context of the industry. Companies in the medical technology sector, like Derma Sciences, are increasingly recognising the importance of sustainability and are often influenced by the climate strategies of their parent organisations. In this case, emissions data and climate commitments may be cascaded from Integra LifeSciences Holdings Corporation, which is responsible for reporting and managing emissions at a higher corporate level. In summary, while Derma Sciences, Inc. does not currently provide specific emissions data or reduction targets, its climate commitments may be shaped by its relationship with Integra LifeSciences Holdings Corporation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 13,902,000 | 00,000,000 | 0,000,000 |
| Scope 2 | 18,609,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Derma Sciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
